Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2025 08:00 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC)...
April 30, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight

New York, USA, April 30, 2025 (GLOBE NEWSWIRE) -- Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight In recent years, the...
April 30, 2025 01:00 ET | Source: F. Hoffmann-La Roche Ltd

CHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings

Positive recommendation based on clinical, real-world and bioequivalence data supporting feasibility and safety of Phesgo’s administration outside of clinical settings, for example at home1-4 Phesgo...
April 29, 2025 08:00 ET | Source: Ardelyx, Inc.

Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class...
April 29, 2025 01:00 ET | Source: F. Hoffmann-La Roche Ltd

Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer

The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial...
April 28, 2025 12:00 ET | Source: Questex LLC

Digital Health Networks Partners with Questex’s Fierce Pharma Week; Unveils Third Annual CINEHEALTH International Film and Video Festival 2025 Jury Members

LOS ANGELES and NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Digital Health Networks, a global leader in healthcare-focused original content production and OTT streaming, is partnering with...
April 28, 2025 08:00 ET | Source: ArriVent BioPharma, Inc.

ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

NEWTOWN SQUARE, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of...
April 25, 2025 04:23 ET | Source: Research and Markets

Antibody Drug Conjugates Market and Forecast to 2030: Trends, Developments and Shares by Type of ADC, Application, Region and Company

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
April 25, 2025 01:00 ET | Source: F. Hoffmann-La Roche Ltd

New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the influenza virus, from an infected person to household members by...
April 24, 2025 06:45 ET | Source: BioNTech SE

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025

MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data for selected assets from its diversified oncology pipeline, including mRNA cancer...